Effects of immunosuppressive drugs on COVID-19 severity in patients with autoimmune hepatitis.
- Efe, Cumali
- Lammert, Craig
- Taşçılar, Koray
- Dhanasekaran, Renumathy
- Ebik, Berat
- Higuera-de la Tijera, Fatima
- Calışkan, Ali R
- Peralta, Mirta
- Gerussi, Alessio
- Massoumi, Hatef
- Catana, Andreea M
- Purnak, Tugrul
- Rigamonti, Cristina
- Aldana, Andres J G
- Khakoo, Nidah
- Nazal, Leyla
- Frager, Shalom
- Demir, Nurhan
- Irak, Kader
- Melekoğlu-Ellik, Zeynep
- Kacmaz, Hüseyin
- Balaban, Yasemin
- Atay, Kadri
- Eren, Fatih
- Alvares-da-Silva, Mario R
- Cristoferi, Laura
- Urzua, Álvaro
- Eşkazan, Tuğçe
- Magro, Bianca
- Snijders, Romee
- Barutçu, Sezgin
- Lytvyak, Ellina
- Zazueta, Godolfino M
- Demirezer-Bolat, Aylin
- Aydın, Mesut
- Heurgue-Berlot, Alexandra
- De Martin, Eleonora
- Ekin, Nazım
- Yıldırım, Sümeyra
- Yavuz, Ahmet
- Bıyık, Murat
- Narro, Graciela C
- Kıyıcı, Murat
- Akyıldız, Murat
- Kahramanoğlu-Aksoy, Evrim
- Vincent, Maria
- Carr, Rotonya M
- Günşar, Fulya
- Reyes, Eira C
- Harputluoğlu, Murat
- Aloman, Costica
- Gatselis, Nikolaos K
- Üstündağ, Yücel
- Brahm, Javier
- Vargas, Nataly C E
- Güzelbulut, Fatih
- Garcia, Sandro R
- Aguirre, Jonathan
- Anders, Margarita
- Ratusnu, Natalia
- Hatemi, Ibrahim
- Mendizabal, Manuel
- Floreani, Annarosa
- Fagiuoli, Stefano
- Silva, Marcelo
- Idilman, Ramazan
- Satapathy, Sanjaya K
- Silveira, Marina
- Drenth, Joost P H
- Dalekos, George N
- N Assis, David
- Björnsson, Einar
- Boyer, James L
- Yoshida, Eric M
- Invernizzi, Pietro
- Levy, Cynthia
- Montano-Loza, Aldo J
- Schiano, Thomas D
- Ridruejo, Ezequiel
- Wahlin, Staffan
DOIAbstract
To access publisher's full text version of this article click on the hyperlink belowBackground: We investigated associations between baseline use of immunosuppressive drugs and severity of Coronavirus Disease 2019 (COVID-19) in autoimmune hepatitis (AIH). Patients and methods: Data of AIH patients with laboratory confirmed COVID-19 were retrospectively collected from 15 countries. The outcomes of AIH patients who were on immunosuppression at the time of COVID-19 were compared to patients who were not on AIH medication. The clinical courses of COVID-19 were classified as (i)-no hospitalization, (ii)-hospitalization without oxygen supplementation, (iii)-hospitalization with oxygen supplementation by nasal cannula or mask, (iv)-intensive ca...